Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (221-230 of 436) with videos related to

Pageof 44
Sort By:
Neurology|April 1, 1987
Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16J P Glass, P Van Tassel, M J Keating, et al.
Blood|May 1, 1987
Clinical investigation of human alpha interferon in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K B McCredie, et al.
Leukemia|July 30, 2003
Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implicationsJ S Carew, Y Zhou, M Albitar, et al.
JAMA|August 4, 1989
Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemiaM M Crane, M J Keating, J M Trujillo, et al.
The American Journal of the Medical Sciences|January 1, 1984
A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignanciesR D Lawson, L O Gentry, G P Bodey, et al.
Cancer Treatment Reports|April 1, 1978
Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatmentV Rodriguez, K B McCredie, M J Keating, et al.
Blood|September 15, 1995
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemiaJ Cortes, S M O'Brien, S Pierce, et al.
Investigational New Drugs|June 1, 1988
Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administrationA M Maddox, E J Freireich, M J Keating, et al.
The American Journal of Medicine|March 1, 1985
Prospective randomized trial of antibiotic prophylaxis in acute leukemiaG P Bodey, M J Keating, K B McCredie, et al.
Cancer|May 15, 1987
The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemiaR Dekmezian, H M Kantarjian, M J Keating, et al.
Pageof 44

Showing results (221-230 of 436) with videos related to

Sort By:
Pageof 44
Neurology|April 1, 1987
Central nervous system complications of a newly recognized subtype of leukemia: AMML with a pericentric inversion of chromosome 16J P Glass, P Van Tassel, M J Keating, et al.
Blood|May 1, 1987
Clinical investigation of human alpha interferon in chronic myelogenous leukemiaM Talpaz, H M Kantarjian, K B McCredie, et al.
Leukemia|July 30, 2003
Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implicationsJ S Carew, Y Zhou, M Albitar, et al.
JAMA|August 4, 1989
Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemiaM M Crane, M J Keating, J M Trujillo, et al.
The American Journal of the Medical Sciences|January 1, 1984
A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignanciesR D Lawson, L O Gentry, G P Bodey, et al.
Cancer Treatment Reports|April 1, 1978
Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatmentV Rodriguez, K B McCredie, M J Keating, et al.
Blood|September 15, 1995
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemiaJ Cortes, S M O'Brien, S Pierce, et al.
Investigational New Drugs|June 1, 1988
Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administrationA M Maddox, E J Freireich, M J Keating, et al.
The American Journal of Medicine|March 1, 1985
Prospective randomized trial of antibiotic prophylaxis in acute leukemiaG P Bodey, M J Keating, K B McCredie, et al.
Cancer|May 15, 1987
The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemiaR Dekmezian, H M Kantarjian, M J Keating, et al.
Pageof 44